133 related articles for article (PubMed ID: 8768828)
61. Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles.
Jacks T; Hickey G; Judith F; Taylor J; Chen H; Krupa D; Feeney W; Schoen W; Ok D; Fisher M
J Endocrinol; 1994 Nov; 143(2):399-406. PubMed ID: 7830002
[TBL] [Abstract][Full Text] [Related]
62. Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels.
Vermeulen A
J Clin Endocrinol Metab; 1987 May; 64(5):884-8. PubMed ID: 3558729
[TBL] [Abstract][Full Text] [Related]
63. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.
Bach MA; Rockwood K; Zetterberg C; Thamsborg G; Hébert R; Devogelaer JP; Christiansen JS; Rizzoli R; Ochsner JL; Beisaw N; Gluck O; Yu L; Schwab T; Farrington J; Taylor AM; Ng J; Fuh V;
J Am Geriatr Soc; 2004 Apr; 52(4):516-23. PubMed ID: 15066065
[TBL] [Abstract][Full Text] [Related]
64. Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK-677.
Svensson J; Carlsson B; Carlsson LM; Jansson JO; Bengtsson BA
Clin Endocrinol (Oxf); 1999 Apr; 50(4):451-6. PubMed ID: 10468903
[TBL] [Abstract][Full Text] [Related]
65. Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients.
Deuschle M; Blum WF; Strasburger CJ; Schweiger U; Weber B; Körner A; Standhardt H; Gotthardt U; Schmider J; Pflaum CD; Heuser I
Psychoneuroendocrinology; 1997 Oct; 22(7):493-503. PubMed ID: 9373883
[TBL] [Abstract][Full Text] [Related]
66. The effect of treatment with the oral growth hormone (GH) secretagogue MK-677 on GH isoforms.
Svensson J; Boguszewski CL; Shibata F; Carlsson B; Carlsson LM; Bengtsson BA
Growth Horm IGF Res; 2003 Feb; 13(1):1-7. PubMed ID: 12550076
[TBL] [Abstract][Full Text] [Related]
67. The acute effects of a low and high dose of oral L-arginine supplementation in young active males at rest.
Forbes SC; Bell GJ
Appl Physiol Nutr Metab; 2011 Jun; 36(3):405-11. PubMed ID: 21574873
[TBL] [Abstract][Full Text] [Related]
68. Effect of alcohol on sleep and nighttime plasma growth hormone and cortisol concentrations.
Prinz PN; Roehrs TA; Vitaliano PP; Linnoila M; Weitzman ED
J Clin Endocrinol Metab; 1980 Oct; 51(4):759-64. PubMed ID: 7419664
[TBL] [Abstract][Full Text] [Related]
69. Daily low-dose administration of growth hormone secretagogue stimulates pulsatile growth hormone secretion and elevates plasma insulin-like growth factor-1 levels in pigs.
Malmlöf K; Bauer MK; Johansen PB; Ankersen M; Veldhuis JD
Endocrine; 2001 Dec; 16(3):195-9. PubMed ID: 11954663
[TBL] [Abstract][Full Text] [Related]
70. Urinary growth hormone and insulin-like growth factor I. Effects of growth-hormone injection schedule.
Albini CH; Quattrin T; Mills B; Sherman B; Johanson A; MacGillivray MH
Clin Pediatr (Phila); 1992 Sep; 31(9):542-5. PubMed ID: 1468171
[TBL] [Abstract][Full Text] [Related]
71. Pulsatile nature of growth hormone levels in critically ill trauma victims.
Melarvie S; Jeevanandam M; Holaday NJ; Petersen SR
Surgery; 1995 Apr; 117(4):402-8. PubMed ID: 7716722
[TBL] [Abstract][Full Text] [Related]
72. Progestin treatment in the dog. I. Effects on growth hormone, insulin-like growth factor I and glucose homeostasis.
Selman PJ; Mol JA; Rutteman GR; Rijnberk A
Eur J Endocrinol; 1994 Oct; 131(4):413-21. PubMed ID: 7921231
[TBL] [Abstract][Full Text] [Related]
73. Body fluids, circadian blood pressure and plasma renin during growth hormone administration: a placebo-controlled study with two growth hormone doses in healthy adults.
Moller J; Jorgensen JO; Frandsen E; Laursen T; Christiansen JS
Scand J Clin Lab Invest; 1995 Dec; 55(8):663-9. PubMed ID: 8903836
[TBL] [Abstract][Full Text] [Related]
74. Relation between growth hormone and cortisol spontaneous secretion in children.
Martinelli CE; Moreira AC
Clin Endocrinol (Oxf); 1994 Jul; 41(1):117-21. PubMed ID: 8050124
[TBL] [Abstract][Full Text] [Related]
75. Absence of ultradian rhythm or diurnal variation in insulin-like growth factor-I in rats.
Donaghue KC; Badger TM; Millard WJ; Frisch LS; Russell WE
Neuroendocrinology; 1990 Jul; 52(1):1-8. PubMed ID: 2118602
[TBL] [Abstract][Full Text] [Related]
76. Reduced growth hormone secretion improves insulin sensitivity in adolescent girls with type 1 diabetes.
Aman J; Kroon M; Karlsson I; Jones I; Hagenäs L
Acta Paediatr; 1996 Jan; 85(1):31-7. PubMed ID: 8834976
[TBL] [Abstract][Full Text] [Related]
77. Single sc administration of insulin-like growth factor I (IGF-I) in normal men.
Hizuka N; Takano K; Asakawa K; Fukuda I; Sukegawa I; Shizume K; Demura H
Adv Exp Med Biol; 1991; 293():105-12. PubMed ID: 1767729
[TBL] [Abstract][Full Text] [Related]
78. Theodore R. Woodward Award. Age-related decline in growth hormone secretion: clinical significance and potential reversibility.
Thorner MO
Trans Am Clin Climatol Assoc; 1997; 108():99-105; discussion 105-8. PubMed ID: 9108670
[TBL] [Abstract][Full Text] [Related]
79. Effect of training on GH and IGF-1 responses to a submaximal exercise in football players.
Mejri S; Bchir F; Ben Rayana MC; Ben Hamida J; Ben Slama C
Eur J Appl Physiol; 2005 Dec; 95(5-6):496-503. PubMed ID: 16151829
[TBL] [Abstract][Full Text] [Related]
80. Reproducibility of 24-hour serum growth hormone profiles in man.
Saini S; Hindmarsh PC; Matthews DR; Pringle PJ; Jones J; Preece MA; Brook CG
Clin Endocrinol (Oxf); 1991 Jun; 34(6):455-62. PubMed ID: 1889130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
